|
RPS6KB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.436160E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.19090000000066E-05 |
| Normal-vs-Stage2 |
6.639800E-02 |
| Normal-vs-Stage3 |
7.663900E-03 |
| Normal-vs-Stage4 |
4.486400E-02 |
| Stage1-vs-Stage2 |
8.010400E-01 |
| Stage1-vs-Stage3 |
3.647400E-01 |
| Stage1-vs-Stage4 |
6.094000E-02 |
| Stage2-vs-Stage3 |
8.228200E-01 |
| Stage2-vs-Stage4 |
4.906200E-01 |
| Stage3-vs-Stage4 |
4.430000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.247110E-04 |
| Normal-vs-AfricanAmerican |
9.218200E-02 |
| Normal-vs-Asian |
2.243600E-02 |
| Caucasian-vs-AfricanAmerican |
3.094400E-01 |
| Caucasian-vs-Asian |
5.370000E-01 |
| AfricanAmerican-vs-Asian |
2.485200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.277740E-03 |
| Normal-vs-Female |
6.28539999999456E-05 |
| Male-vs-Female |
1.937400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.677200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.758300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.577800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.175200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.638200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.223000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.226800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.089200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.063400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.942400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.019300E-04 |
| Normal-vs-Grade 2 |
2.87070000004608E-06 |
| Normal-vs-Grade 3 |
1.027770E-02 |
| Normal-vs-Grade 4 |
1.795350E-01 |
| Grade 1-vs-Grade 2 |
2.232800E-01 |
| Grade 1-vs-Grade 3 |
5.798500E-03 |
| Grade 1-vs-Grade 4 |
4.842200E-03 |
| Grade 2-vs-Grade 3 |
2.483400E-03 |
| Grade 2-vs-Grade 4 |
1.799330E-03 |
| Grade 3-vs-Grade 4 |
3.646000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.80189999985114E-07 |
| Normal-vs-ccB subtype |
7.700400E-03 |
| ccA subtype-vs-ccB subtype |
2.037600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.175800E-04 |
| Normal-vs-N1 |
1.452380E-01 |
| N0-vs-N1 |
8.022200E-01 |
|
|
